Plasmid DNA-entrapped nanoparticles engineered from microemulsion precursors: In vitro and in vivo evaluation

Bioconjugate Chemistry

Volumn 13, Issue 6, 2002, Pages 1319-1327

  Cui, Zhengrong ^a   Mumper, Russell J ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; CATIONIC SURFACTANTS; CYTOLOGY; DNA; DYES; EMULSIFICATION; GEL PERMEATION CHROMATOGRAPHY; GENE THERAPY; MAMMALS; MOLECULAR BIOLOGY;

DELIVERY SYSTEMS; IN-VITRO; NONVIRAL GENE THERAPY; OIL-IN-WATER MICROEMULSIONS; PLASMID DNA; PULLULANS; TAIL VEIN INJECTIONS; TWEEN-20; VITRO AND IN VIVO; VIVO EVALUATION;

NANOPARTICLES;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CELL CULTURE; CHEMISTRY; EMULSION; FEMALE; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; METHODOLOGY; MOUSE; NANOTECHNOLOGY; PARTICLE SIZE; PLASMID; TISSUE DISTRIBUTION;

ANIMALS; EMULSIONS; FEMALE; GENE THERAPY; HUMANS; MICE; MICE, INBRED BALB C; NANOTECHNOLOGY; PARTICLE SIZE; PLASMIDS; TISSUE DISTRIBUTION; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0036861734     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc0255586     Document Type: Article

References (34)

1. Bailey, A. L., and Sullivan, S. M. (2000) Efficient encapsulation of DNA plasmids in small neutral liposomes induced by ethanol and calcium. Biochim. Biophys. Acta 1468, 239-252.
2. Chesnoy, S., Durand, D., Doucet, J., Stolz, D. B., and Huang, L. (2001) Improved DNA/emulsion complex stabilized by poly-(ethylene glycol) conjugated phospholipids. Pharm. Res. 18, 1480-1484.
3. Chesnoy, S., and Huang, L. (2000) Structure and function of lipid-DNA complexes for gene delivery. Annu. Rev. Biophys. Biomol. Struct. 29, 27-47.
4. Clark, M., and Hersh, E. M. (1999) Cationic lipid-mediated gene transfer: Current concepts. Curr. Opin. Mol. Ther. 1, 158-76.
5. Cui, Z. R., and Mumper, R. J. (2002a) Genetic immunization using nanoparticles engineered from microemulsion precursors. Pharm. Res. 19, 939-946.
6. Cui, Z. R., and Mumper, R. J. (2002b) Topical immunization using nanoengineered genetic vaccines. J. Controlled Release 81, 173-184.
7. Hara, T., Tan, Y., and Huang, L. (1997a) In vivo gene delivery to the liver using reconstituted chylomicron remnants as a novel nonviral vector. Proc. Natl. Acad. Sci. U.S.A. 94, 14547-14552.
8. Hara, T., Liu, F., Liu, D., and Huang, L. (1997b) Emulsion formulation as a vector for gene delivery in vitro and in vivo. Adv. Drug Del. Rev. 24, 265-271.
9. Hong, M. S., Lim, S. J., Oh, Y. K., and Kim, C. K. (2002) pH-sensitive, serum-stable and long-circulating liposomes as a new drug delivery system. J. Pharm. Pharmocol. 54, 51-58.
10. Houk, B. E., Martin, R., Hochhaus, C., and Hughes, J. A. (2001) Pharmacokinetics of plasmid DNA in the rat. Pharm. Res. 18, 67-74 (2001).
11. Ishiwata, H., Suzuki, N., Ando, S., Kikuchi, H., and Kitagawa, T. (2000) Characteristics and biodistribution of cationic liposome and their DNA complexes. J. Controlled Release 69, 139-148.
12. Kaneo, Y., Tanaka, T., Nakano, T., and Yamaguchi, Y. (2001). Evidence for receptor-mediated hepatic uptake of pullulan in rats. J. Controlled Release 70, 365-373.
13. Kawabata, K., Takakura, Y., and Hashida, M. (1995) The fate of plasmid DNA after intravenous injection in mice: Involvement of scavenger receptors in its hepatic uptake, Pharm. Res. 12, 825-830.
14. Liu, F., and Huang, L. (2002) Development of nonviral vectors for systemic gene delivery. J. Controlled Release 78, 259-266.
15. Lundberg, B. B., Mortimer, B. C., and Redgrave, T. G. (1996) Submicron lipid emulsions containing amphipathic poly(ethylene glycol) for use as drug-carriers with prolonged circulation time. Int. J. Pharm. 134, 119-127.
16. Mahato, R. I., Kawabata, K., Nomura, T., Takakura, Y., and Hashida, M. (1995a) Physicochemical and pharmacokinetics characteristics of plasmid DNA/cationic liposome complexes. J. Pharm. Sci. 84, 1267-1271.
17. Mahato, R. I., Kawabata, K., Takakura, Y., and Hashida, M. (1995b) In vivo disposition characteristics of plasmid DNA complexed with cationic liposomes. J. Drug Target. 3, 149-157.
18. Minchin, R. F., Carpenter, D., Orr, R. J., (2001) Polyinosinic acid and polycationic liposomes attenuate the hepatic clearance of circulating plasmid DNA. J. Pharmacol. Exp. Ther. 296, 1006-1012.
19. Mosqueira, V. C. F., Legrand, P., Morgat, J., Vert, M., Mysiakine, E., Gref, R., Devissaguet, J., and Barratt, G. (2001) Biodistribution of long-circulating PEG-grafted nanocapsules in mice: Effects of PEG chain length and density. Pharm. Res. 18, 1411-4119.
20. Nishikawa, M., Takakura, Y., and Hashida, M. (1998) Biofate of Fat Emulsions, in Submicron Emulsions in Drug Targeting and Delivery (S. Benita, Ed.) pp 99-118, Harwood Academic Publishers, Amsterdam.
21. Nishikawa, M., Takemura, S., Yamashita, F., Takakura, Y., Meijer, D. K., Hashida, M., and Swart, P. J. (2000a) Pharmacokinetics and in vivo gene transfer of plasmid DNA complexed with mannosylated poly(L-lysine) in mice. J. Drug Target. 8, 29-38.
22. Nishikawa, M., Yamauchi, M., Morimoto, K., Ishida, E., Takakura, Y., and Hashida, M. (2000b) Hepatocyte-targeted in vivo gene expression by intravenous injection of plasmid DNA complexed with synthetic multi-functional gene delivery system. Gene Ther. 7, 548-555.
23. Oh, Y. K., Kim, J. P., Yoon, H., Kim, J. M., Yang, J. S., and Kim, C. K. (2001) Prolonged organ retention and safety of plasmid DNA administered in polyethylenimie complexes. Gene Ther. 8, 1587-1592.
24. Pam, P., Monck, M., Lee, D., Ludkovski, O., Leng, E. C., Clow, K., Stark, H., and Scherrer, P. (2000) Stabilized plasmid-lipid particles for systemic gene therapy. Gene Ther. 7, 1867-1874.
25. Patel, H. M. (1992) Serum opsonins and liposomes: Their interaction and opsonophagocytosis. Crit Rev. Ther. Drug Carrier Syst. 9, 1437-1446.
26. Reimer, D. L., Zhang, Y. P., Kong, S., Wheeler, J. J., Graham, R. W., and Bally, M. B. (1995) Formation of novel hydrophobic complexes between cationic lipids and plasmid DNA. Biochemistry 34, 12877-12883.
27. Rolland, A., and Felgner, P., Eds. (1998) Nonviral gene delivery systems. Adv. Drug Deliv. Rev. 30, 1-227.
28. Sakaeda, T., and Hirano, K. (1998) Effect of composition on biological fate of oil particles after intravenous injection of O/W lipid emulsion. J. Drug Target. 6, 273-284.
29. Tabata, Y., Matsui, Y., Uno, K., Sokawa, Y., and Ikada, Y. (1999) Simple mixing of IFN with a polysaccharide having high liver affinity enables IFN to target to the liver. J. Interferon Cytokine Res. 19, 287-292.
30. Takakura, Y., Nishikawa, F., Yamashita, F., and Hashida, M. (2001) Development of gene drug delivery systems based on pharmacokinetic studies. Eur. J. Pharm. Sci. 13, 71-76.
31. Verbaan, F. J., Oussoren, C., van Dam, I. M., Takakura, Y., Hashida, M., Crommelin, D. A. J., Hennink, W. E., and Storm, G. (2001) The fate of poly(2-dimethyl amino ethyl)-methacrylate-based polyplexes after intravenous administration. Int. J. Pharm. 214, 99-101.
32. Wheeler, J. J., Palmer, L., Ossanlou, M., MacLachlan, I., Graham, R. W., Zhang, Y. P., Hope, M. J., Scherrer, P., and Cullis, P. R. (1999) Stabilized plasmid-lipid particles: Construction and characterization. Gene Ther. 6, 271-281.
33. Xi, K., Tabata, Y., Uno, K., Yoshimoto, M., Kishida, T., Sokawa, Y., Ikada, Y. (1996) Liver targeting of interferon through pullulan conjugation. Pharm. Res. 13, 1846-1850.
34. Yoshida, M., Mahato, R. I., Kawabata, K., Takakura, T., and Hashida, M. (1997) Disposition characteristics of plasmid DNA in the single-pass rat liver perfusion. Pharm. Res. 12, 597-603.